Hallmarks of Cancer: New Dimensions
- PMID: 35022204
- DOI: 10.1158/2159-8290.CD-21-1059
Hallmarks of Cancer: New Dimensions
Abstract
The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. SIGNIFICANCE: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of "big data" about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.
©2021 American Association for Cancer Research.
Similar articles
-
AKT and the Hallmarks of Cancer.Cancer Res. 2024 Dec 16;84(24):4126-4139. doi: 10.1158/0008-5472.CAN-24-1846. Cancer Res. 2024. PMID: 39437156 Review.
-
Cancer hallmarks intersect with neuroscience in the tumor microenvironment.Cancer Cell. 2023 Mar 13;41(3):573-580. doi: 10.1016/j.ccell.2023.02.012. Cancer Cell. 2023. PMID: 36917953 Free PMC article. Review.
-
Updates of cancer hallmarks in patients with inborn errors of immunity.Curr Opin Allergy Clin Immunol. 2022 Dec 1;22(6):352-363. doi: 10.1097/ACI.0000000000000863. Epub 2022 Sep 21. Curr Opin Allergy Clin Immunol. 2022. PMID: 36165433 Free PMC article. Review.
-
Hallmarks of cancer-the new testament.Open Biol. 2021 Jan;11(1):200358. doi: 10.1098/rsob.200358. Epub 2021 Jan 20. Open Biol. 2021. PMID: 33465324 Free PMC article. Review.
-
Cancer Evolution: A Multifaceted Affair.Cancer Discov. 2024 Jan 12;14(1):36-48. doi: 10.1158/2159-8290.CD-23-0530. Cancer Discov. 2024. PMID: 38047596 Free PMC article.
Cited by
-
The preclinical pharmacokinetics of Tolinapant-A dual cIAP1/XIAP antagonist with in vivo efficacy.Pharmacol Res Perspect. 2024 Dec;12(6):e70030. doi: 10.1002/prp2.70030. Pharmacol Res Perspect. 2024. PMID: 39450695 Free PMC article.
-
Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results from a High-Volume Center.Dig Surg. 2024;41(3):111-121. doi: 10.1159/000540181. Epub 2024 Jul 18. Dig Surg. 2024. PMID: 38981458 Free PMC article.
-
Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review).Int J Oncol. 2024 Feb;64(2):17. doi: 10.3892/ijo.2023.5605. Epub 2023 Dec 22. Int J Oncol. 2024. PMID: 38131226 Free PMC article. Review.
-
Exploring Novel Frontiers in Cancer Therapy.Biomedicines. 2024 Jun 18;12(6):1345. doi: 10.3390/biomedicines12061345. Biomedicines. 2024. PMID: 38927551 Free PMC article.
-
Spheroid Model of Mammary Tumor Cells: Epithelial-Mesenchymal Transition and Doxorubicin Response.Biology (Basel). 2024 Jun 21;13(7):463. doi: 10.3390/biology13070463. Biology (Basel). 2024. PMID: 39056658 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
-
- Yuan S, Norgard RJ, Stanger BZ. Cellular plasticity in cancer. Cancer Discov. 2019;9:837–51.
-
- Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608–11.
-
- Perekatt AO, Shah PP, Cheung S, Jariwala N, Wu A, Gandhi V, et al. SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium. Cancer Res. 2018;78:4878–90.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials